Remote Patient Monitoring Market Report 2026

The remote patient monitoring market size has grown rapidly in recent years. It will grow from $55.24 billion in 2025 to $63.75 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the growing burden of chronic diseases, the increasing aging population, the rising demand for home-based healthcare, the expanding adoption of telehealth services, and the growing focus on reducing hospital readmissions.

The remote patient monitoring market size is expected to see rapid growth in the next few years. It will grow to $111.93 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing prevalence of chronic and lifestyle-related diseases, rising demand for home healthcare services, growing patient awareness of remote monitoring benefits, increasing healthcare expenditure globally, and rising focus on value-based and outcome-driven care. Major trends in the forecast period include advancements in wearable sensor technologies, innovations in remote monitoring platforms and software solutions, developments in the integration of remote patient data with electronic health records, research and developments in predictive analytics for patient monitoring, and advancements in artificial intelligence-driven clinical decision support.

The increasing prevalence of chronic diseases is expected to drive the growth of the remote patient monitoring market in the coming years. Chronic diseases are long-term health conditions such as hypertension, diabetes, and cardiovascular disorders that require continuous monitoring and ongoing management. Their prevalence is rising due to aging populations and widespread unhealthy lifestyle habits, including physical inactivity, poor nutrition, tobacco use, and excessive alcohol consumption, which contribute to long-term risks such as obesity, hypertension, and diabetes. Remote patient monitoring supports chronic disease management by continuously tracking patients’ vital signs, symptoms, and treatment adherence from home. It enhances patient outcomes by enabling early detection of complications, timely interventions, and personalized care adjustments. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Consequently, the rising prevalence of chronic diseases is fueling the expansion of the remote patient monitoring market.

Major companies in the remote patient monitoring market are focusing on developing advanced remote monitoring products to enhance patient care, support clinical decision-making, and expand access to medical-grade data. Remote vital signs monitoring systems are wearable devices that continuously and accurately track key physiological parameters for use in clinical, emergency, and home settings. For example, in May 2024, Sempulse Corporation, a US-based medical device manufacturer, launched the FDA 510(k)-cleared Halo Vital Signs Monitoring System, a compact wearable device that integrates with the LiveCharts mobile app and the Command Cloud platform for centralized data visualization and management. The system features a reusable design suitable for both home and clinical use, cloud-based data analytics to prioritize patient care, and continuous monitoring of vital signs even during patient activity.

In June 2024, ResMed Inc., a US-based provider of digital health solutions, acquired Inhealthcare Limited for an undisclosed amount. Through this acquisition, ResMed aims to expand its remote patient monitoring and virtual ward capabilities in the UK, enhancing its service offerings and extending the impact of patient care across integrated care systems. Inhealthcare Limited is a UK-based provider of remote patient monitoring services, including virtual wards, remote care for hypertension and COPD, digital care home monitoring, medication reminders, and falls prevention solutions.

Major companies operating in the remote patient monitoring market are Siemens AG, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Baxter International Inc., Roche Diagnostics, Omron Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., ResMed Inc., Dräger Medical, Dexcom Inc., Teladoc Health Inc., Nihon Kohden Corporation, OSI Systems Inc, Biofourmis Inc., Masimo Corp., VitalConnect Inc., Guangdong Transtek Medical Electronics Co. Ltd.

North America was the largest region in the remote patient monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote patient monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the remote patient monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the remote patient monitoring market by increasing the cost of imported sensors, wearable devices, communication modules, and semiconductor components used in monitoring hardware. healthcare providers in north america and europe are most affected due to reliance on imported medical electronics, while asia-pacific faces cost pressures on device manufacturing and exports. these tariffs are raising device procurement costs and slowing large-scale deployment programs. however, they are also encouraging local manufacturing of medical devices, regional sourcing of components, and increased investment in domestic digital health ecosystems.

Remote patient monitoring is a healthcare approach that utilizes digital technologies to collect medical data from patients outside traditional clinical settings. It allows continuous tracking of health indicators, including vital signs, symptoms, and treatment responses, in real time. This approach enhances early detection, improves care management, and enables timely medical intervention without the need for in-person visits.

The primary components of remote patient monitoring include devices, services, and software. Devices are used to remotely collect patients’ vital signs and health data, enabling continuous monitoring, early detection of health issues, and timely intervention. Different applications include chronic disease management, post-acute care monitoring, preventive care and wellness, home health monitoring, and rehabilitation monitoring, and they are used by several end users comprising hospitals, clinics, home healthcare providers, ambulatory care centers, and long-term care facilities.

The remote patient monitoring market consists of revenues earned by entities by providing services such as remote monitoring service, telehealth consultation service, data analytics service, clinical interpretation service, and technical support service. The market value includes the value of related goods sold by the service provider or included within the service offering. The remote patient monitoring market also includes sales of wearable monitoring devices, vital sign sensors, blood pressure monitors, glucose monitoring devices, pulse oximeters, and electrocardiogram monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.